PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9589663-7	1998	During the acute octreotide test, the GH nadir was significantly lower in the gsp-positive adenomas (85% of maximal inhibition vs. 52%).	Octreotide	17-27	GNAS complex locus	Homo sapiens	78-81	
9589663-8	1998	Eighteen patients were treated with octreotide (300 micrograms/day) for at least 3 months before surgery: the percent inhibition of GH hypersecretion was higher in gsp-positive adenomas (76% vs. 47%).	Octreotide	36-46	GNAS complex locus	Homo sapiens	164-167	
9589663-9	1998	In cell culture, the octreotide-induced inhibition of GH release was significantly higher in gsp-positive adenomas (71% vs. 30%).	Octreotide	21-31	GNAS complex locus	Homo sapiens	93-96